Boston Scientific Corp's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Total-Cash-From-Operating-Activities" stands at 4.63 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.
Boston Scientific Corp's third quarter result of 1.34 Billion USD for the item "Total Cash From Operating Activities" represents an increase of 4.43 percent compared to it's second quarter result.
Also, Boston Scientific Corp's third quarter result of 1.34 Billion USD for the item "Total Cash From Operating Activities" represents an increase of 34.03 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Boston Scientific Corp's third quarter result of 4.63 Billion USD for the item "Total Cash From Operating Activities" represents an increase of 7.96 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 57.56 percent compared to the value the year prior.
The 1 year change in percent is 57.56.
The 3 year change in percent is 286.47.
The 5 year change in percent is 202.95.
The 10 year change in percent is 550.63.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Abbott Laboratories - Total Cash From Operating Activities | 217,696,616,448.00 |
![]() | Intuitive Surgical Inc - Total Cash From Operating Activities | 206,245,888,000.00 |
![]() | EssilorLuxottica S. A. - Total Cash From Operating Activities | 172,241,486,586.05 |
![]() | Danaher Corporation - Total Cash From Operating Activities | 162,006,663,168.00 |
![]() | Stryker Corporation - Total Cash From Operating Activities | 139,209,850,880.00 |